Clinical trial
Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary…
NCT00350844 · Ann & Robert H Lurie Children's Hospital of Chicago, Other · Terminated
Key facts
| NCT number | NCT00350844 |
|---|---|
| Title | Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension |
| Official title | A Pilot Study of Hydroxyurea for the Treatment of Pulmonary Hypertension in Children and Young Adults With Sickle Cell Disease |
| Lead sponsor | Ann & Robert H Lurie Children's Hospital of Chicago, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Sickle Cell Disease, Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | Hydroxyurea |
| Enrollment | 6 |
| Start date | Jul 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Jul 11, 2006 |
| Last update posted | Aug 6, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: